We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.64B
Cap. Flow %
-83.08%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169

Top Buys

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$604M
2
SPLK
Splunk Inc
SPLK
+$446M
3
HES
Hess
HES
+$339M
4
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$106M
5
X
US Steel
X
+$50.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.06B
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$887M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$371M
4
VMW
VMware, Inc
VMW
+$354M
5
NEWR
New Relic, Inc.
NEWR
+$284M

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Real Estate 7.26%
5 Industrials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATRC icon
351
AtriCure
ATRC
$2.07B
$435K 0.01%
12,199
-37,094
-75% -$1.38M
SCYX icon
352
SCYNEXIS
SCYX
$53.3M
$423K 0.01%
23,683
-22,069
-48% -$324K
LCID icon
353
Lucid Motors
LCID
$2.75B
$421K 0.01%
+10,000
New +$449K
VKTX icon
354
Viking Therapeutics
VKTX
$3.94B
$412K 0.01%
22,141
-35,764
-62% -$468K
NERV icon
355
Minerva Neurosciences
NERV
$205M
$398K 0.01%
64,644
-5,356
-8% -$30.6K
PHAT icon
356
Phathom Pharmaceuticals
PHAT
$678M
$394K 0.01%
43,209
-74,071
-63% -$638K
MARA icon
357
Marathon Digital Holdings
MARA
$3.85B
$393K 0.01%
+16,749
New +$211K
PMVP icon
358
PMV Pharmaceuticals
PMVP
$64.5M
$391K 0.01%
+126,000
New +$333K
CYTK icon
359
CALL
Cytokinetics
CYTK
$10.4B
$387K 0.01%
+10,000
New +$362K
ALT icon
360
Altimmune
ALT
$595M
$386K 0.01%
+34,298
New +$143K
EVLVW
361
DELISTED
Evolv Technologies Warrant
EVLVW
$380K 0.01%
478,241
-214,959
-31% -$139K
TSLA icon
362
Tesla
TSLA
$1.29T
$373K 0.01%
1,500
-1,000
-40% -$238K
BCRX icon
363
BioCryst Pharmaceuticals
BCRX
$2.41B
$360K 0.01%
60,159
-181,661
-75% -$1.05M
CRNX icon
364
Crinetics Pharmaceuticals
CRNX
$8.9B
$357K 0.01%
10,038
-16,115
-62% -$494K
CCL icon
365
PUT
Carnival Corporation Ltd
CCL
$39.3B
$347K 0.01%
1,021,500
+106,500
+12% +$1.55M
IMCR icon
366
CALL
Immunocore
IMCR
$1.7B
$340K 0.01%
+25,000
New +$1.3M
CNTX icon
367
Context Therapeutics
CNTX
$46.3M
$335K 0.01%
296,675
+975
+0.3% +$1.05K
IFRX icon
368
InflaRx
IFRX
$272M
$329K 0.01%
201,880
-188,120
-48% -$322K
SNDX icon
369
CALL
Syndax Pharmaceuticals
SNDX
$1.79B
$326K 0.01%
75,000
-5,000
-6% -$76.9K
XRX icon
370
PUT
Xerox
XRX
$429M
$307K 0.01%
248,800
– –
DCPH
371
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$290K 0.01%
120,000
+70,000
+140% +$893K
ASAN icon
372
Asana
ASAN
$2.13B
$285K 0.01%
15,000
-70,000
-82% -$1.36M
CHGG icon
373
Chegg
CHGG
$99.9M
$284K 0.01%
25,000
– –
FAF icon
374
First American
FAF
$7.64B
$269K 0.01%
+4,169
New +$238K
SCRMW
375
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$262K 0.01%
+573,164
New +$91.4K
13 14
15
16 17

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.64B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.